MLchartDataset catalogue

Myeloablative chemotherapy

Term · Oncology and biomedicine · MLC-T-ONC-005620

High-dose chemotherapy that kills cells in the bone marrow, including cancer cells. It lowers the number of normal blood-forming cells in the bone marrow, and can cause severe side effects. Myeloablative chemotherapy is usually followed by a bone marrow or stem cell transplant to rebuild the bone marrow.

Table 1. Record
IdentifierMLC-T-ONC-005620
FieldOncology and biomedicine
ReferencesNCI Dictionary of Cancer Terms
Record as JSON 
{
  "id": "MLC-T-ONC-005620",
  "term": "Myeloablative chemotherapy",
  "field": "Oncology and biomedicine",
  "definition": "High-dose chemotherapy that kills cells in the bone marrow, including cancer cells. It lowers the number of normal blood-forming cells in the bone marrow, and can cause severe side effects. Myeloablative chemotherapy is usually followed by a bone marrow or stem cell transplant to rebuild the bone marrow.",
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/myeloablative-chemotherapy/"
}

Record 11,503 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.